Financial Performance and Guidance - Cardinal Health raises its fiscal year 2026 non-GAAP diluted EPS guidance to at least $10.00, up from the previous range of $9.65 to $9.85[5] - The company anticipates approximately $3.4 billion in operating earnings for fiscal year 2026[19] - Cardinal Health expects approximately $3.25 billion in adjusted free cash flow for fiscal year 2026[20] Specialty Growth - Specialty revenue is projected to exceed $50 billion in fiscal year 2026, representing a 16% compound annual growth rate (CAGR) over three years[5, 35] - BioPharma Solutions is expected to grow over 30% in fiscal year 2026[37, 45] - Cardinal Health's MSOs contribute approximately $4.5 billion in higher-margin revenue[42] Strategic Initiatives - Cardinal Health is introducing ContinuCare Pathway to simplify diabetes supply management for pharmacies and patients, partnering with Publix Super Markets Inc[7] - The company is prioritizing growth in therapeutic areas such as autoimmune, urology, and oncology[37] - Cardinal Health aims to achieve $1 billion in higher-margin revenue from BioPharma Solutions by fiscal year 2028[43] Overall Strategy - Cardinal Health is focused on simplification, expanding in Specialty, accelerating other growth businesses, and executing GMPD Improvement Plan initiatives[34] - The company highlights a consistent track record, unique breadth of capabilities, and a resilient business model[57]

Core Viewpoint - Cardinal Health, Inc. has raised its fiscal 2026 earnings outlook, projecting non-GAAP diluted earnings per share to be at least $10, up from a previous range of $9.65 to $9.85, indicating improved operational performance [1] - The company expects Specialty revenues to exceed $50 billion during fiscal 2026, representing a 16% compounded annual growth rate over three years [2] Medicare Pricing Transition - Cardinal Health successfully transitioned pharmaceutical distribution agreements affected by the Medicare Drug Price Negotiation Program changes ahead of implementation, ensuring appropriate compensation for its distribution services [3] - The company introduced the ContinuCare Pathway program under its at-Home Solutions business to simplify diabetes supply management and insurance navigation for patients and partner pharmacies [4] Broad Business Scope - Cardinal Health is a major distributor of pharmaceuticals, specialty products, and medical and laboratory supplies, also providing performance solutions and direct-to-patient services across the healthcare sector [5] - At the time of publication, Cardinal Health shares rose by 4.08% to $210.77, trading near its 52-week high of $214.93 [5]